Back to search

Genesys Biotech Ltd

04603049

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

2ND FLOOR BUTLER HOUSE, LONDON, W1T 7AF
Incorporated 27/11/2002

Compliance

Last accounts

31/03/2025

total exemption full

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 04/12/2025

Due 18/12/2026

On track

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Mrs Sarah Louise Dugdale

director · Since 30/03/2023

SENIOR SCIENTIST

BRITISH · ENGLAND · Age 51

Also on 5 other boards

Dr Nicholas Richard Morant

director · Since 30/03/2023

SENIOR SCIENTIST

BRITISH · ENGLAND · Age 43

Also on 2 other boards

Persons with Significant Control

Genesys Biotech Eot Limited

75–100% shares
75–100% votes
Appoint directors

2nd Floor Butler House, 177-178 Tottenham Court Road, London, W1T 7AF

Reg: 16041162 · Register Of Companies · Private Company Limited By Shares

Notified 30/10/2024

Former PSCs

Dr Duncan Roy Clark

Ceased 30/03/2023

Dr Nicholas Richard Morant

Ceased 30/10/2024

Mrs Sarah Louise Dugdale

Ceased 30/10/2024

CompanyRankvs 61+ SIC 72190 peers
89

Financial strength99th percentile among SIC peers · 25/25
Employees95th percentile among SIC peers · 14/15
LiquidityCurrent ratio 28.62× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Kemet International Limited
90
2R.B. Radley & Company Limited
90
3Tom Martin & Company Limited
90
4Sra Developments Limited
90
5Drumgrange Limited
90
6Giro Engineering Limited
90
7Hydronix Limited
90
8Fluid Gravity Engineering Limited
90
9Innovative Technology Limited
90
10Scanna Msc Limited
90
61Genesys Biotech Ltd
89
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£11.0M

Balance sheet strength

Cash

£9.3M

Cash in the bank

Net Current Assets

£10.2M

Working capital

Current Assets

£10.5M

Current Liabilities

£368k

Fixed Assets

£980k

Debtors

£994k

13avg. employees

Balance Sheet

Assets less current liabilities£11.2M
Signed by S L Dugdale 31 March 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202528.62+£0
202528.62-£20.2M
202439.94+£4k
202399.80-£936k
202219.33—
20212.73—
202019.08+£281k
20194.48+£218k
20187.98+£410k
20179.53—

Derived from filed accounts. Not audited figures.